Thursday, Nov 23 2017 | Time 14:33 Hrs(IST)
image
  • US, 2 other envoys present credentials to Prez
  • Myanmar, Bangladesh sign Rohingya return deal - Myanmar official
  • Australia rally late to restrict England
  • School student attacked by outsiders in Mah
  • European shares slip on Thanksgiving Thursday, Centrica crashes
  • Pondy Govt will waive corp loan of farmers: CM
  • Zimbabwe's economic situation "very difficult" - IMF mission chief
  • Tornado in Indonesia injures 35, damages hundreds of homes
  • Mitsubishi Materials says units falsified product data
  • Two die in bus-car collision in Baghpat
  • Fadnavis unveils 1st look of World Orange Festival 2017
  • Two-way traffic allowed on Mughal road, one-way on Leh highway
  • Huge consignment of banned medicine bottles seized
  • Tension after ulema attacked in train
  • Zimbabwe's economic situation "very difficult" - IMF mission chief
Science & Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.
The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers.
Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies.
Over 35 oncologists in India have already screened patients using our Oncotrack.
Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.
' India is likely to have over 1.
73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020.
Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low.
'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies.
We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome.
The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country.
The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood.
Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers.
The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.
This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option.
Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment.
The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre.
UNI ST SS RSA SB 1043

Environmental

Environmental health risks especially affect women and children

Kolkata, Nov 20 (UNI) Environmental health risks especially affect women
and children, because they are more vulnerable socially and because
exposures to environmental contaminants create greater risks for children’s developing bodies and cognitive functions.

Hydrogen

Hydrogen can become great tool against climate change

New Delhi, Nov 19 (UNI) Greater use of hydrogen for energy can considerably reduce CO2 emissions compared to today’s levels, says a study.

Cipla

Cipla Receives Final Approval for Generic Pulmicort Respules

Mumbai, Nov 17(UNI) Pharma major, Cipla Ltd, today said that it
has received final approval for its Abbreviated New Drug Application
(ANDA) for Budesonide Inhalation Suspension, 0.

Antibiotic

Antibiotic resistance is one of the biggest threats to global health

Kolkata, Nov 14 (UNI) Antibiotic resistance is one of the biggest threats to global health, food security and development today.

Drop

Drop in cases of plague in Madagascar: WHO

Geneva, Nov 4 (UNI) While progress has been made in response to the plague outbreak in Madagascar, and the number of suspected new cases continues to decline, the World Health Organisation (WHO) has said that sustaining operations through the remainder of the plague season would be critical as there was still a risk of potential further spread of the disease.

Solar eclipse 2017: North America will witness total solar eclipse

Solar eclipse 2017: North America will witness total solar eclipse

New York, Aug 21 (UNI) Today, all of North America will witness a total solar eclipse for the first time in 99 years, where the Moon will pass in front of the Sun, casting darkness across swathes of the Earth's surface - with up to 14 states shrouded in complete blackout.

Nano-particle fertilizer could lead to new 'green revolution'

Nano-particle fertilizer could lead to new 'green revolution'

New Delhi, Jan 26 (UNI) Sri Lankan scientists report having developed a simple way to make a benign, more efficient fertilizer – described as nano-particle fertilizer - that could contribute to a second food revolution across the globe.

Broken pebbles offer clues to Palaeolithic funeral rituals

Broken pebbles offer clues to Palaeolithic funeral rituals

New Delhi, Feb 9 (UNI) Humans may have ritualistically "killed" objects to remove their symbolic power, some 5,000 years earlier than previously thought, a new international study of marine pebble tools from an Upper Palaeolithic burial site in Italy suggests.

image